Abstract
There is increasing evidence that diabetes mellitus and Alzheimers disease occur more often than by chance. Recently, we proposed that increase in the activity of the enzyme butyrylcholinesterase could be a common link between these two conditions. Acetylcholine is an anti-inflammatory molecule. Butyrylcholinesterase by inactivating acetylcholine may enhance inflammation and induce decline in cognitive function. In the present study, it was noted that streptozotocininduced diabetic animals showed dyslipidemia, increase in plasma lipid peroxides, decrease in circulating plasma superoxide dismutase activity, decline in cognitive function as assessed by the Morris water maze method, and a significant increase in serum butyrylcholinesterase activity. These results suggest that increased plasma and, possibly, tissue concentrations of butyrylcholinesterase lead to decrease in acetylcholine levels, an anti-inflammatory molecule, which may trigger low-grade systemic inflammation in diabetes mellitus and Alzheimers disease that could account for decline in cognitive function.
Keywords: Diabetes mellitus, Alzheimer's disease, hyperlipidemia, hyperglycemia, anti-oxidants, lipid peroxidation, cognitive function, butyrylcholinesterase, acetylcholine, inflammation
Current Nutrition & Food Science
Title: Enhanced Butyrylcholinesterase Activity may be the Common Link in Triggering Low-Grade Systemic Inflammation and Decrease in Cognitive Function in Diabetes Mellitus and Alzheimers disease
Volume: 4 Issue: 3
Author(s): Allam A. Rao, C. Siva Reddy, G. R. Sridhar, A. Annapurna, T. Hanuman, M. Prameela, K. Suresh, S. Prasannalaxmi and Undurti N. Das
Affiliation:
Keywords: Diabetes mellitus, Alzheimer's disease, hyperlipidemia, hyperglycemia, anti-oxidants, lipid peroxidation, cognitive function, butyrylcholinesterase, acetylcholine, inflammation
Abstract: There is increasing evidence that diabetes mellitus and Alzheimers disease occur more often than by chance. Recently, we proposed that increase in the activity of the enzyme butyrylcholinesterase could be a common link between these two conditions. Acetylcholine is an anti-inflammatory molecule. Butyrylcholinesterase by inactivating acetylcholine may enhance inflammation and induce decline in cognitive function. In the present study, it was noted that streptozotocininduced diabetic animals showed dyslipidemia, increase in plasma lipid peroxides, decrease in circulating plasma superoxide dismutase activity, decline in cognitive function as assessed by the Morris water maze method, and a significant increase in serum butyrylcholinesterase activity. These results suggest that increased plasma and, possibly, tissue concentrations of butyrylcholinesterase lead to decrease in acetylcholine levels, an anti-inflammatory molecule, which may trigger low-grade systemic inflammation in diabetes mellitus and Alzheimers disease that could account for decline in cognitive function.
Export Options
About this article
Cite this article as:
Rao A. Allam, Reddy Siva C., Sridhar R. G., Annapurna A., Hanuman T., Prameela M., Suresh K., Prasannalaxmi S. and Das N. Undurti, Enhanced Butyrylcholinesterase Activity may be the Common Link in Triggering Low-Grade Systemic Inflammation and Decrease in Cognitive Function in Diabetes Mellitus and Alzheimers disease, Current Nutrition & Food Science 2008; 4 (3) . https://dx.doi.org/10.2174/157340108785133310
DOI https://dx.doi.org/10.2174/157340108785133310 |
Print ISSN 1573-4013 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3881 |
Call for Papers in Thematic Issues
Functional Foods in Human Health and Beyond
Foods are important source of nutrients including carbohydrates, proteins, lipids and other minerals. Furthermore, the functional foods are those agents that have additional components that are essential supports to the body in terms of antioxidant and pharmacologically active agents. The predominant functional foods are of plant in origin, whereas some ...read more
Harnessing Bioactive Compounds from Food Waste: Sustainable Extraction Strategies and Health Applications
Food waste presents a significant challenge across the postharvest cycle, from agricultural production to distribution. However, within this waste lies a treasure trove of bioactive chemicals that hold immense potential for nutraceuticals, functional foods, and postharvest additives, including antimicrobials. Various extraction methods, such as solvent extraction (SE), supercritical fluid extraction ...read more
Natural Bioactive Compounds Derivatives in Nutraceutical and Food Science
In the last years, plants have been widely used for their numerous properties and now there is growing interest in the study of classes of compounds obtained from plant species or derived from them. The importance of these natural compounds lies in their important therapeutic purposes, and in their capability ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Biomarkers of Alzheimer's Disease Risk in Peripheral Tissues; Focus on Buccal Cells
Current Alzheimer Research Integration of Internet of Things with Quantum Dots: A State-of-the-art of Medicine
Current Pharmaceutical Design Propranolol Safety Profile in Children
Current Drug Safety Hypoglycemic and Hypolipemic Effects of a New Lecithin Formulation of Bergamot Polyphenolic Fraction: A Double Blind, Randomized, Placebo- Controlled Study
Endocrine, Metabolic & Immune Disorders - Drug Targets The Mineralocorticoid Receptor in Endothelial Physiology and Disease: Novel Concepts in the Understanding of Erectile Dysfunction
Current Pharmaceutical Design The Hypothalamic-Neurohypophyseal System: Current and Future Treatment of Vasopressin and Oxytocyn Related Disorders
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 11 Years of Cyanopyrrolidines as DPP-IV Inhibitors
Current Topics in Medicinal Chemistry Editorial:
Endocrine, Metabolic & Immune Disorders - Drug Targets Emerging Role for RBM20 and its Splicing Substrates in Cardiac Function and Heart Failure
Current Pharmaceutical Design Poly-Pharmacy Among the Elderly: Analyzing the Co-Morbidity of Hypertension and Diabetes
Current Pharmaceutical Design Pharmacokinetic Study and Trial for Preparation of Enteric-Coated Capsule Containing Insulinomimetic Vanadyl Compounds: Implications for Clinical Use
Mini-Reviews in Medicinal Chemistry Studies on α-Glucosidase Inhibitors Development: Magic Molecules for the Treatment of Carbohydrate Mediated Diseases
Mini-Reviews in Medicinal Chemistry Current Perspectives for Diabetes and Allostatic Load: The Role of Nutrition
Current Nutrition & Food Science Serum Hepcidin, the Hepcidin/Ferritin Ratio and the Risk of Type 2 Diabetes: A Systematic Review and Meta-Analysis
Current Medicinal Chemistry Melatonin and Male Reproductive Health: Relevance of Darkness and Antioxidant Properties
Current Molecular Medicine Drug Repositioning for Treatment of Movement Disorders: From Serendipity to Rational Discovery Strategies
Current Topics in Medicinal Chemistry Amniotic Fluid Stem Cells: a Promising Therapeutic Resource for Cell-Based Regenerative Therapy
Current Pharmaceutical Design Glycemic Goal for Older Adults with Diabetes and Concentrated Basal Insulin Options
Applied Clinical Research, Clinical Trials and Regulatory Affairs Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis
Current Medicinal Chemistry Novel Therapeutic Targets for Management of Type-2 Diabetes Mellitus
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)